News
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Linda Jónsdóttir Linda Jonsdottir, Alvotech's new Chief Financial Officer REYKJAVIK, ICELAND (July 10, 2025) — Alvotech ...
Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt ...
Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.
Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...
Seeking Alpha on MSN5d
Alvotech acquires Ivers-Lee GroupAlvotech ( NASDAQ: ALVO) is expanding its capacity for assembly and packaging with the acquisition of Ivers-Lee Group. Based in Burgdorf, Switzerland, Ivers-Lee provides assembly and packaging ...
Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred ...
Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred ...
--Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief ...
Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has ...
REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar ...
Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US. Alvotech is challenging the patent thicket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results